Search
for
Sort by
Research 301–330 of 1000+
- The evolution of primary multimodality treatment in resectable breast cancer
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Dermatologic Adverse Events from Cancer Treatments
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Hair disorders in patients with cancer
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Limited stage small cell lung cancer
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Efficacy of Platelet-rich Plasma for Treating Androgenic Alopecia of Varying Grades
- Transcriptomic inspection revealed a possible pathway regulating the formation of the high-quality brush hair in Chinese Haimen goat ( <i>Capra hircus</i> )
- Nobiletin-loaded composite penetration enhancer vesicles restore the normal miRNA expression and the chief defence antioxidant levels in skin cancer
- The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial
- Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Comparative efficacy of oral dutasteride and low-, medium-, and high-dose oral minoxidil: a six-month prospective trichoscopic and clinical study
- Diabetes, ovarian tumor, hyperparathyroidism, and papillary cancer: A chance association?
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- An investigation of vitamin D status in alopecia areata
- Factors associated with female pattern hair loss and its prevalence in Taiwanese women: A community-based survey
- Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia
- Retrospective evaluation of Penguin Cold Caps for chemotherapy-induced alopecia